COMMUNIQUÉS West-GlobeNewswire

NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth
17/06/2026
BOCA RATON, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID: MAJI) today announced a strategic pivot, evolutionary restructuring, and operational alignment designed to [...]
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
17/06/2026
- Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million of additional capacity funded at amendment closing - WALTHAM, Mass., June 17, 2026 (GLOBE NEWSWIRE) -- Dyne [...]
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
17/06/2026
Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinism (HI), as well as previously reported results from the Company’s Phase 3 sunRIZE study in congenital HI and a case [...]
Christian Wichert appointed Chief Executive Officer to lead next phase of growth
17/06/2026
Senior executive across industrial biotechnology and consumer markets with strong expertise in commercialization joins AMSilk as the Company advances from development through scale-up to market growth The announcement [...]
BrewDog Turns Up Father’s Day Across the U.K. with Gift-Ready Beer, Custom Cans and Dads Eat Free
17/06/2026
From standout beer gifts to nationwide bar experiences, BrewDog is bringing bold flavour and big Father’s Day energy to dads across the U.K. ELLON, Scotland, June 17, 2026 (GLOBE NEWSWIRE) -- Scottish brewer, BrewDog , [...]
Trading in GN Store Nord shares by board members, executives and associated persons
17/06/2026
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
17/06/2026
Pharmaceutical executive and physician with strong experience in global research and development Over 20 years’ experience in all stages of clinical development across multiple indications, including neurology and [...]
Avricore Health Closes $1.254 Million Financing
17/06/2026
VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore” ) announces that, further to its news release dated May 20, 2026, the Company has closed its [...]
Glass House Brands Announces its Deconsolidation of its Dual-Use Business and its Application for Uplisting of Shares to NYSE
17/06/2026
LONG BEACH, Calif. and TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that it has applied to list its subordinate [...]
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
17/06/2026
~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter of 2026 ~ LEXINGTON [...]
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
17/06/2026
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of 100% and to repurchase $25 million of [...]
Trevi Therapeutics Announces Upcoming June and July Event Schedule
17/06/2026
NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data [...]
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
17/06/2026
A data-driven repricing solution that optimizes cost management and complements existing bill review workflows FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (Nasdaq: CRVL), a national provider [...]
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
17/06/2026
Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease RAMAT GAN, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a [...]
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
17/06/2026
TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. (“Sernova” or the “Company”) (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused on developing [...]
Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia
17/06/2026
Saint-Genis-Pouilly, France, 17 June 2026 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that it has advanced dencatistat, the Company’s first-in- [...]
Des preuves inédites montrent comment un modèle fondé sur l’entrepreneuriat peut réduire l’extrême pauvreté parmi les réfugiés
17/06/2026
De nouvelles études montrent que le programme DREAMS augmente les revenus, l’épargne et la résilience des communautés de réfugiés en Afrique de l’Est La Fondation IKEA a engagé 7,4 millions de dollars pour financer la [...]
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
17/06/2026
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development [...]

Pages